Christopher Siracusa

455 total citations
23 papers, 251 citations indexed

About

Christopher Siracusa is a scholar working on Pulmonary and Respiratory Medicine, Clinical Psychology and General Health Professions. According to data from OpenAlex, Christopher Siracusa has authored 23 papers receiving a total of 251 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Pulmonary and Respiratory Medicine, 4 papers in Clinical Psychology and 3 papers in General Health Professions. Recurrent topics in Christopher Siracusa's work include Cystic Fibrosis Research Advances (18 papers), Family and Disability Support Research (3 papers) and Respiratory viral infections research (2 papers). Christopher Siracusa is often cited by papers focused on Cystic Fibrosis Research Advances (18 papers), Family and Disability Support Research (3 papers) and Respiratory viral infections research (2 papers). Christopher Siracusa collaborates with scholars based in United States, Netherlands and Australia. Christopher Siracusa's co-authors include Jamie L. Ryan, Dennis Drotar, Yu Wang, John P. Clancy, Nanhua Zhang, Dennis C. Stokes, Jennifer L. Goralski, Andres F. Carrion, Saumini Srinivasan and Denis Hadjiliadis and has published in prestigious journals such as American Journal of Respiratory and Critical Care Medicine, The Journal of Pediatrics and Journal of Pediatric Gastroenterology and Nutrition.

In The Last Decade

Christopher Siracusa

19 papers receiving 244 citations

Peers

Countries citing papers authored by Christopher Siracusa

Since Specialization

Citations

This map shows the geographic impact of Christopher Siracusa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher Siracusa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher Siracusa more than expected).

Fields of papers citing papers by Christopher Siracusa

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher Siracusa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher Siracusa. The network helps show where Christopher Siracusa may publish in the future.

Co-authorship network of co-authors of Christopher Siracusa

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher Siracusa. A scholar is included among the top collaborators of Christopher Siracusa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher Siracusa. Christopher Siracusa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Acceptability of Telehealth Post‐Pandemic Among Clinicians Across the United States Caring for People With Cystic Fibrosis 2025 ·Pediatric Pulmonology ·(unknown), (unknown), Julianna Bailey, (unknown), Bryan Garcia, Deborah Froh, (unknown), Christopher Siracusa, G. Sawicki	1
2	Effects of Therapeutic Antibiotic Exposure on the Oropharyngeal and Fecal Microbiota in Infants With Cystic Fibrosis 2025 ·Pediatric Pulmonology ·Hillary S. Hayden, Maria T. Nelson, (unknown), Adrian J. Verster, Drake C. Bouzek, (unknown), Adam Waalkes, Kelsi Penewit, Benjamin T. Kopp, Christopher Siracusa, Michael J. Rock, Stephen J. Salipante, Lucas R. Hoffman, Don B. Sanders	0
3	“Time out for an hour, every day, my whole life”: understanding treatment burden in cystic fibrosis in the era of Elexacaftor/Tezacaftor/Ivacaftor (ETI) 2025 ·Journal of Cystic Fibrosis ·Jennifer Butcher, Christopher Siracusa, (unknown), (unknown), (unknown), (unknown), (unknown), Robin S. Everhart, Jill Maggs, Michelle Prickett, Alex H. Gifford, Nicole Mayer‐Hamblett, David P. Nichols, Kristin A. Riekert, Gregory S. Sawicki	0
4	Qualitative understanding of experiences of people with cystic fibrosis in a treatment discontinuation trial: The QUEST study 2024 ·Contemporary Clinical Trials ·Jill Maggs, G. Sawicki, (unknown), (unknown), (unknown), (unknown), Lisa Sweeney, Jennifer Butcher, Robin S. Everhart, Michelle Prickett, Christopher Siracusa, Alex H. Gifford, Nicole Mayer‐Hamblett, David P. Nichols, (unknown), (unknown), Kristin A. Riekert	1
5	Predicting lung function decline in cystic fibrosis: the impact of initiating ivacaftor therapy 2024 ·Respiratory Research ·(unknown), (unknown), (unknown), Eleni‐Rosalina Andrinopoulou, (unknown), Gary L. McPhail, Christopher Siracusa, (unknown), Rhonda D. Szczesniak	0
6	Nasal airway inflammatory responses and pathogen detection in infants with cystic fibrosis 2023 ·Journal of Cystic Fibrosis ·Benjamin T. Kopp, (unknown), (unknown), Lokesh Guglani, Joshua D. Chandler, Rabindra Tirouvanziam, (unknown), James E. Slaven, James F. Chmiel, Christopher Siracusa, Don B. Sanders	1
7	Built environment factors predictive of early rapid lung function decline in cystic fibrosis 2023 ·Pediatric Pulmonology ·(unknown), Cole Brokamp, (unknown), (unknown), Eleni‐Rosalina Andrinopoulou, Judith W. Dexheimer, John Clancy, Ruth H. Keogh, Yizhao Ni, (unknown), (unknown), (unknown), (unknown), (unknown), Christopher Siracusa, Patrick Ryan, Rhonda D. Szczesniak	5
8	Longitudinal mental health trends in cystic fibrosis 2023 ·Journal of Cystic Fibrosis ·(unknown), Elizabeth Hente, Jamie L. Miller, (unknown), James Peugh, (unknown), (unknown), Md Monir Hossain, Christopher Siracusa, Stephanie S. Filigno	5
9	503 Perceptions of treatment burden for people with cystic fibrosis on highly effective modulator therapy after a withdrawal study 2023 ·Journal of Cystic Fibrosis ·James N. Butcher, (unknown), Henry G. Grabowski, Christopher Siracusa, Gregory S. Sawicki	1
10	Patient and family perceptions of telehealth as part of the cystic fibrosis care model during COVID-19 2021 ·Journal of Cystic Fibrosis ·(unknown), Alexander P. Nesmith, (unknown), Julianna Bailey, Christopher Siracusa, (unknown), (unknown), Gregory S. Sawicki, George M. Solomon	44
11	Implementing and adapting FEV1-indicated exacerbation signal algorithms through quality improvement 2020 ·Pediatric Pulmonology ·Christopher Siracusa, Denis Leonard, (unknown), Lisa A. Mullen, (unknown), Raouf Amin	1
12	A Pilot Study of Mindfulness-Based Cognitive Therapy to Improve Well-Being for Health Professionals Providing Chronic Disease Care 2020 ·The Journal of Pediatrics ·Elizabeth Hente, Richard W. Sears, Sian Cotton, Harini Pallerla, Christopher Siracusa, Stephanie S. Filigno, Thomas F. Boat	9
13	Assessing and responding to stress related to pulmonary function testing in cystic fibrosis through quality improvement 2020 ·Pediatric Pulmonology ·(unknown), Stephanie S. Filigno, (unknown), Elizabeth Hente, Elizabeth A. Koch, Lisa A. Mullen, (unknown), Thomas F. Boat, Christopher Siracusa	8
14	Acute Respiratory Distress Syndrome immediately following the removal of an aspirated foreign body 2019 ·Respiratory Medicine Case Reports ·(unknown), Charles M. Myer, Christopher Siracusa	0
15	Reduction of Recurrence Risk of Pancreatitis in Cystic Fibrosis With Ivacaftor 2017 ·Journal of Pediatric Gastroenterology and Nutrition ·Andres F. Carrion, Drucy Borowitz, Steven D. Freedman, Christopher Siracusa, Jennifer L. Goralski, Denis Hadjiliadis, Saumini Srinivasan, Dennis C. Stokes	51
16	Non‐typeable Haemophilus influenzae purulent pericarditis in a child with cystic fibrosis 2016 ·Pediatrics International ·Kevin J. Downes, Kamal Abulebda, Christopher Siracusa, Ryan A. Moore, Mary Allen Staat, Sue E. Poynter	1
17	Update in Pediatric Lung Disease 2014 2015 ·American Journal of Respiratory and Critical Care Medicine ·Christopher Siracusa, John J. Brewington, (unknown), Theresa W. Guilbert	3
18	Adherence Determinants in Cystic Fibrosis: Cluster Analysis of Parental Psychosocial, Religious, and/or Spiritual Factors 2015 ·Annals of the American Thoracic Society ·Daniel H. Grossoehme, Rhonda D. Szczesniak, (unknown), Christopher Siracusa, Alexandra L. Quittner, Barbara A. Chini, (unknown), Michael Seid	26
19	Electronic monitoring reveals highly variable adherence patterns in patients prescribed ivacaftor 2015 ·Journal of Cystic Fibrosis ·Christopher Siracusa, Jamie L. Ryan, (unknown), Yu Wang, Nanhua Zhang, John P. Clancy, Dennis Drotar	49
20	The impact of transforming healthcare delivery on cystic fibrosis outcomes: a decade of quality improvement at Cincinnati Children’s Hospital 2014 ·BMJ Quality & Safety ·Christopher Siracusa, (unknown), James D. Acton, (unknown), Barbara A. Chini, (unknown), (unknown), Raouf Amin, Gary L. McPhail	24

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact